Leadership change is routine and unlikely to move the stock. Monitor next quarterly earnings for any commercial execution impact under new leadership.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Sep 16 $3.86entry
- T+1 · 2mo ago +7.25%α +6.12% · $4.14
- T+5 · 8w ago +3.89%α +1.32% · $4.01
- T+20 · 5w ago +5.70%α +2.52% · $4.08
- T+43 · todayOpen
- T+60 · in 23d Pending
Price Chart
How similar events traded
Executive Summary
Myriad Genetics announced the promotion of Vishal Sikri to EVP-Commercial, replacing departing CCO Brian Donnelly. The company reaffirmed its full-year 2026 financial guidance. This is a routine leadership change with no material financial impact.
Key Facts
- Vishal Sikri promoted to EVP-Commercial, effective September 16, 2026.
- Brian Donnelly, Chief Commercial Officer since May 2025, departing September 21, 2026.
- Full-year 2026 financial guidance reaffirmed.
Financial Impact
No financial figures provided; guidance reaffirmed.
Risk Factors
- Departure of CCO Brian Donnelly after ~16 months could signal commercial challenges.
- No new financial targets or updates provided.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3363090 |
Track record
16 reports on MYGN
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.54% at T+5 after the Oct 20, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry price pending
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $5.67 to $5.72 Now $5.57 −1.76% ▲ +0.88% −0.44% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $6.29 to $5.92 Now $5.57 −11.45% ▼ −5.88% −6.19% vs SPY
- Nov 4, 202612d ago 8-K Mixed 6/10 Entry $6.29 to $5.92 Now $5.57 −11.45% ▼ −5.88% −6.19% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $6.02 to $6.29 Now $5.57 −7.48% ▲ +4.49% +8.89% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $6.63 to $6.67 Now $5.57 −15.99% ▲ +0.60% +0.99% vs SPY
- Oct 20, 202627d ago 8-K Bullish 7/10 Entry $5.54 to $5.57 Now $5.57 +0.54% ▲ +0.54% +0.02% vs SPY
- Oct 15, 20264w ago Press Release Neutral 1/10 Entry $3.98 Now $5.57 +39.95% No price data
- Oct 9, 20265w ago 8-K Neutral 3/10 Entry $4.20 to $4.08 Now $5.57 +32.62% ▼ −2.86% −2.85% vs SPY
- Sep 16, 20268w ago 8-K Neutral 3/10 Entry $3.86 to $4.14 Now $5.57 +44.30% ▲ +7.25% +6.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers